Washington, DC, United States of America

Xuexiang Du

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Xuexiang Du: Pioneering Advances in Cancer Immunotherapy

Introduction

Xuexiang Du, based in Washington, DC, is a distinguished inventor with an impressive portfolio comprising three patents. His work primarily revolves around the development of innovative solutions for cancer immunotherapy, aiming to improve treatment outcomes while minimizing adverse effects.

Latest Patents

One of Xuexiang Du's notable patents is focused on CD80 and CD86 binding protein compositions and their application in mitigating autoimmune adverse events associated with cancer immunotherapy. This invention reveals the potential of CTLA-4 protein compositions in enhancing the safety and efficacy of cancer treatments. Another significant patent involves the creation of mutant anti-CTLA-4 antibodies with improved immunotherapeutic effects but reduced adverse effects. This patent describes antibody compositions that target the human CTLA-4 molecule, offering a promising avenue for cancer immunotherapy while addressing the challenge of autoimmune side effects commonly associated with other treatment agents.

Career Highlights

Throughout his career, Xuexiang Du has notably contributed to the field as part of organizations such as Oncoc4, Inc. and Children's National Medical Center. His efforts in these companies have been pivotal in advancing research and developing innovative therapies, showcasing his commitment to improving cancer treatment strategies.

Collaborations

Xuexiang Du has collaborated with several esteemed colleagues, including Yang Liu and Pan Zheng. These partnerships have fostered an environment conducive to groundbreaking discoveries, reinforcing the importance of teamwork in scientific research and innovation.

Conclusion

Xuexiang Du's contributions to the field of cancer immunotherapy represent significant strides in the ongoing battle against cancer. With his trio of patents emphasizing safety and effectiveness, he is a critical figure in enhancing treatment modalities for patients, making a lasting impact on the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…